| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 29, 2013
Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration...
-
May 29, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval for the generic version of Sanctura XR®. Perrigo had...
-
May 23, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it is transferring the listing of its U.S. traded common stock to the New York Stock...
-
May 13, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced it has kicked off a broad industry marketing and communications campaign to raise awareness for,...
-
May 8, 2013Flash, a Yellow Lab from California, takes the title.
Flash, a three-year-old yellow Labrador Retriever with a talent for learning tricks and a healthy smile, took the top spot in the Superstar Smiles Photo...
-
May 7, 2013- Fiscal third quarter net sales increased 18% year over year to a record $920 million.
Perrigo Company (Nasdaq: PRGO; TASE: PRGO) today announced results for its third quarter ended March 30, 2013. (Logo:...
-
May 2, 2013
Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on June 18,...
-
Apr 23, 2013
Perrigo Company (Nasdaq: PRGO;TASE:) today announced that it will release financial results for its third quarter fiscal year 2013 on Tuesday,...
-
Apr 1, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has closed the acquisition of Velcera, Inc. ("Velcera"), Yardley, Pennsylvania based pet...
-
Mar 18, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its...